2022
DOI: 10.1016/s0735-1097(22)02893-5
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective Trial of Carvedilol in Early-Stage Breast Cancer Patients With Abnormal Strain Treated With Anti-Her-2 Therapy (Protect Her-2)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles